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AHeterosubtypic Immunity to Lethal Influenza A Virus Infection Is Associated with Virus-
Specific CD81 Cytotoxic T Lymphocyte Responses Induced in Mucosa-Associated Tissues1
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Heterosubtypic immunity, defined as cross-reactive immune responses to influenza virus of a different serotype than the
virus initially encountered, was investigated in association with virus-specific cytotoxic T lymphocyte (CTL) responses
induced in systemic and mucosa-associated lymph nodes after immunization via different routes. Mice immunized by the
pulmonary route with live nonpathogenic influenza virus, strain Udorn (H3N2), survived challenge with mouse-adapted
pathogenic influenza virus, strain PR/8/34 (H1N1). These mice developed strong heterosubtypic CTL responses in spleen,
cervical lymph nodes (CLN), and mediastinal lymph nodes (MLN). Alternately, only 20% of mice immunized intravenously,
intraperitoneally, or intranasally survived the challenge; all of these developed CTL responses in spleen and CLN, but not in
MLN. Direct correlation between short-term and long-term memory heterosubtypic CTL responses induced in MLN and host
recovery after lethal infection indicates that these CTL responses may play an important role in heterosubtypic immunity.
Furthermore, induction and maintenance of memory CTL in regional mucosa-associated lymphoid tissues are highly
dependent on mucosal immunization. The results implicate the mechanism of heterosubtypic immunity and should be an
important consideration in the development of protective mucosal vaccines against variant strains of influenza and HIV.
© 1999 Academic Pressn
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sINTRODUCTION
Influenza virus undergoes periodic antigenic shifts in
ts two outer membrane glycoproteins, hemagglutinin
nd neuraminidase, thereby abrogating humoral cross-
rotection of different virus strains. However, cross-pro-
ection between different subtypes of influenza A virus is
ediated by heterosubtypic immunity in the absence of
irus-specific antibodies recognizing the outer mem-
rane proteins (Schulman and Kilbourne, 1965). Hetero-
ubtypic immunity to influenza virus infection is thought
o be mediated by serotype cross-reactive cytotoxic T
ymphocytes (CTLs) specific for the influenza nucleopro-
ein, a conserved gene product (Townsend et al., 1984;
ewdell et al., 1985; Taylor et al., 1987; Wraith et al., 1987).
assive transfer of large numbers of in vitro activated T
ells possessing subtype-specific cytotoxic activity to
nfluenza virus-infected mice can reduce pulmonary virus
iters, promote their recovery, and provide protection in
ertain circumstances (Yap and Ada, 1978; Yap et al.,
978; Lin and Askonas, 1981; Wells et al., 1983; Lukacher
t al., 1984; Taylor and Askonas, 1986). However, it has
een more difficult to induce resistance by active immu-
1 This work was supported in part by US PHS Grant AI-28147, T32 AI
7150, contracts AI-65298 and AI-65299, and the CF464 pilot study.
2 To whom correspondence and reprint requests should be ad-
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50ization with shared antigens, such as NP and M pro-
eins (Askonas et al., 1982). Immunization with recombi-
ant NP (Wraith et al., 1987; Tite et al., 1990), with NP
xpressed by poxvirus vectors (Andrew et al., 1987; An-
rew and Coupar, 1988; Webster et al., 1991), or with
urified M protein (Webster and Hinshaw, 1977) induced
mmune responses; however, subsequent protection
pon challenge with homologous influenza virus is
ometimes partial, but in other cases very weak or even
bsent. Immunization with recombinant vaccinia virus
xpressing an NP epitope recognized by CD81 T cells
eadily induced primary pulmonary NP-specific CD81
TL. No protection by these T cells upon challenge with
irus was observed, as determined by virus titers, clear-
nce kinetics, and survival (Lawson et al., 1994). In vivo
epletion of CD81 T cells by monoclonal antibodies led
o partial but not complete reduction of hetersubtypic
mmunity (Liang et al., 1994), and heterosubtypic immu-
ity was observed in b2-microglobulin-deficient mice
Eichelberger et al., 1991; Bender et al., 1994; Epstein et
l., 1997), raising questions regarding the effector mech-
nism of heterosubtypic immunity.
Mucosal immunization, i.e., total respiratory tract (TRT)
xposure to live virus, has been a route for induction of
eterosubtypic immunity to influenza since the early
tudies (Schulman and Kilbourne, 1965; Yetter et al.,
980) and continues to be used (Liang et al., 1994; Ep-
tein et al., 1997). Since influenza virus, like many other
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51CTL INDUCED IN MUCOSA-ASSOCIATED TISSUES AND PROTECTIONathogens, initiates infection at the mucosal surface of
he respiratory tract, the immune response observed in
ystemic lymphoid organs may not reflect the events
ccurring at the site of infection, i.e., the mucosal sur-
ace. Immunizations through mucosal routes lead to in-
uction of mucosal immune responses mediated by an-
igen-specific secretory IgA (S-IgA) antibodies at the site
f immunization as well as at distant mucosal surfaces
hrough the common mucosal immune system [see re-
iew by McGhee et al. (1987); Mestecky (1987)]. Detec-
ion of cell-mediated cytotoxicity in mucosa-associated
issues suggests that T-cell-mediated immunity is an
mportant component for protection against mucosal
athogens (Davies and Parrott, 1981; Ernst et al., 1985;
ffit and Dudzik, 1989; Offit et al., 1991). Mucosal immu-
ization induces antigen-specific CTL responses pre-
ominantly in mucosa-associated lymphoid organs (Gal-
ichan et al., 1993), and maintenance of antiviral memory
TL in mucosal tissues is dependent on mucosal immu-
ization as well as the time of assessment, as shown in
tudies with recombinant adenovirus vector (Gallichan
nd Rosenthal, 1996). However, it is not clear in these
tudies whether cell-mediated or humoral immune re-
ponses were critical for protection or recovery from
nfection. In addition, the duration of protective antigen-
pecific memory CTL responses in mucosa-associated
issues is not known.
An early study has reported that intraperitoneal immu-
ization followed by TRT challenge with a heterologous
erotype induced heterosubtypic CTL responses in me-
iastinal lymph nodes (MLN) (Bennink et al., 1978); how-
ver, induction of CTL responses in various lymphoid
ompartments following immunization by different routes
nd their correlation with heterosubtypic immunity have
ot been systematically explored. In this study, we pro-
ide evidence that protective heterosubtypic immunity to
FIG. 1. Induction of heterosubtypic CTL activity: BALB/c mice were
R/8/34 (H1N1) (three mice per group), and sacrificed 4 weeks later. Sp
ytotoxic activity. Each effector cell culture was tested against H3N2 a
HC-mismatched EL-4 target cells.ethal influenza virus infection is correlated with hetero-
ubtypic virus-specific CTL responses induced in mu-
osa-associated lymphoid tissues draining the site of
nfection. Furthermore, we demonstrate that mucosal im-
unization as opposed to systemic immunization gener-
tes long-lived protective heterosubtypic virus-specific
TL in a site-restricted fashion in mucosa-associated
ymphoid organs. Heterosubtypic CTL responses in-
uced in the mucosal compartment are discussed with
egard to the effector mechanism of heterosubtypic im-
unity to lethal influenza A virus infection.
RESULTS
nduction of heterosubtypic CTL activity
To establish a model of heterosubtypic immunity,
ALB/c mice were infected intravenously with influenza
irus type A, either strain Udorn (serotype H3N2) or strain
R/8/34 (serotype H1N1). One month later the mice were
acrificed, and spleen cells were isolated, stimulated in
itro, and subjected to the virus-specific cytotoxicity as-
ay. As shown in Fig. 1, heterosubtypic CTL activity to
erotype H3N2 virus in mice immunized with serotype
1N1 virus was of comparable magnitude to homotypic
TL activity to the H1N1 virus at all E:T ratios tested. The
TL activities were measured by subtraction of nonspe-
ific cytotoxic activity against mock-infected MHC-
atched target cells (P815 cell line with H-2d haplotype)
nd MHC-unrestricted cytotoxic activity against target
ells with mismatched MHC haplotype (EL-4 cell line
ith haplotype H-2b). Similarly, both homotypic CTL ac-
ivity and strong heterosubtypic CTL activity specific for
erotype H3N2 and H1N1 were detected in mice immu-
ized with serotype H3N2. The cross-reactive CTL activ-
ties were observed when both the P815 cell line ex-
ressing MHC class I and A20 cells expressing MHC
d intravenously with influenza virus type A, strains Udorn (H3N2) or
lls were isolated, pooled, in vitro stimulated, and assayed for specific
N1 virus-infected 51Cr-labeled MHC-matched P815 and A20 cells andinfecte
leen ce
nd H1
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52 NGUYEN ET AL.lass I and class II were used as target cells. Cytotoxic
ctivities against the uninfected MHC-matched target
ell line P815 (H-2d) and the infected MHC-mismatched
arget EL-4 (H-2b) cells were used as controls in all
xperiments. The results clearly showed that mice in-
ected previously with the nonpathogenic serotype H3N2
train Udorn developed strong homotypic and hetero-
ubtypic CTL activity specific for the serotype H3N2
train and the serotype H1N1 strain PR/8/34, respec-
ively.
urvival of previously immunized mice following
hallenge with mouse-adapted serotype H1N1
Heterosubtypic CTL activity to serotype H1N1 influ-
nza virus can be induced by immunization with serotype
3N2, and this serves as an excellent model for studying
he role of virus-specific CTL in the host following infec-
ion. First, we induced heterosubtypic CTL responses
pecific for influenza type A using various routes of
mmunization with nonpathogenic influenza virus strain
dorn (H3N2). Even with this nonpathogenic virus strain,
he mice immunized throughout the respiratory tract ex-
ibited approximately 5% weight loss during the first 5
ays but regained the weight by day 9. The other groups
f animals did not show any signs of sickness (data not
hown). One month later, 15 mice were divided into
ubgroups of 5 and 10 mice; 5 mice were subjected to
TL assay (see below), another 10 mice were challenged
ith the pathogenic strain (mouse-adapted) PR/8/34
H1N1) via the TRT (250 PFU equivalent to 5 LD50) in 50
L. As shown in Fig. 2a, only the group of mice immu-
ized previously via the TRT with live Udorn virus recov-
red totally (100%), while in the groups of naive mice and
ice infected by intravenous (iv), intraperitoneal (ip), or
ntranasal (i.n.) routes, survival ranged from 0 to 20%.
ice previously infected intravenously with homologous
erotype H1N1 virus were protected from TRT challenge
FIG. 2. Survival and loss of body weight in animals challenged with
ith influenza virus type A Udorn (H3N2) by different routes, as i
ouse-adapted PR/8/34 strain (H1N1) via the TRT. Mortality was monit
easured every 2 days until all animals regained their initial weight (bt a lethal dose. No weight loss was seen in this group
f mice and the protection from secondary infection is
nown to be mediated by preexisting antibody specific
or homologous outer membrane glycoproteins. A tran-
ient weight loss was observed in the group of mice
mmunized via the TRT (Fig. 2b). During the first week
fter challenge, the other groups of heterosubtypically
mmunized and unimmunized mice had severe weight
osses from day 2 to day 6, when mortality was first
bserved.
istribution of heterosubtypic CTL activity in various
ymphoid organs following immunization via different
outes
Although virus-specific CTL responses were gener-
ted after infection by most of the immunization routes,
nly the group of animals immunized by the TRT route
urvived the challenge with the mouse-adapted PR/8/34
train. In the majority of studies performed in the past,
TL responses were usually measured in the spleen.
herefore, we examined the distribution of CTL re-
ponses in spleen and other lymphoid organs after im-
unization by various routes and protection upon sub-
equent challenge. To this end, BALB/c mice were in-
ected with nonpathogenic strain Udorn (H3N2) via iv, ip,
r i.n. routes (107 PFU/10 ml per mouse while awake) or
ia the TRT (107 PFU/50 ml through the nose of an
nesthetized mouse). Four weeks later, on the same day
hat survival was tested by challenge, lymphoid tissues
rom five mice from each group were assayed for CTL
ctivity against serotype H1N1 virus-infected target cells
fter in vitro stimulation. All subgroups of mice had
trong heterosubtypic CTL activity against serotype
1N1 virus-infected target cells in cells from spleen (Fig.
a); i.e., immunizations via iv, i.n., and TRT routes in-
uced strong heterosubtypic CTL activity of similar mag-
itude, while immunization via the ip route induced
-adapted heterologous influenza virus: BALB/c mice were immunized
d. Four weeks later they were challenged with the heterologous
ily for at least 3 weeks (a) and body weight of individual animals was
es are means for 10 mice in each group.mouse
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53CTL INDUCED IN MUCOSA-ASSOCIATED TISSUES AND PROTECTIONomewhat lower heterosubtypic CTL activity. Also, het-
rosubtypic CTL activity was observed following in vitro
timulation of lymphocytes derived from CLN, but it did
ot differ significantly in mice immunized by the different
outes (Fig. 3b). In contrast, stimulated lymphocytes iso-
ated from lungs did not display CTL activity (Fig. 3c).
urprisingly, when lymphocytes isolated from MLN, the
raining lymph nodes of the lungs were stimulated in
itro to measure CTL activity, positive heterosubtypic
TL activity was detected only in MLN of mice immu-
ized via TRT. In vitro stimulated lymphocytes isolated
rom MLN of mice immunized through routes other than
RT remained unresponsive to virus-infected target cells
Fig. 3d). These data clearly showed that immunization
ith live nonpathogenic serotype H3N2 strain Udorn via
RT induced strong secondary heterosubtypic CTL ac-
ivities against serotype H1N1 virus-infected target cells
n both mucosal and systemic lymphoid organs, but not
n the lungs.
ompartmentalized induction of virus-specific CTL
esponses and its correlation with survival rate
A comparison of the distribution of CTL responses in
ifferent lymphoid organs after immunization by various
outes (Fig. 3), and the survival data after challenge (Fig.
a), showed a correlation between the virus-specific CTL
esponse induced in MLN and the recovery from infec-
ion (100% survival). On the other hand, the virus-specific
TL responses induced in other compartments did not
orrelate with recovery following challenge. The survival
ates of the groups of animals immunized via iv, ip, and
.n. routes were similar (20% of survival).
FIG. 3. Distribution of heterosubtypic CTL activity in different lymp
nfected with nonpathogenic H3N2 strain Udorn by different routes, a
ubgroup were sacrificed. Lymphocytes isolated from different lympho
irus-infected P815 target cells. Specific CTL activities were determined
ells.eterosubtypic CTL effector cells at the site of virus
hallenge
Since pneumonia is the cause of death after influenza
nfection, heterosubtypic virus-specific CTL at the site of
nfection may be essential for recovery. We reasoned that
hortly after challenge, memory CTL precursors from
LN may migrate to the lung, the site of infection, and
unction in defense against the pathogen. Two days after
hallenge with mouse-adapted H1N1 influenza virus by
he TRT route, lymphocytes isolated from lungs were
ssayed for virus-specific CTL activity without previous
n vitro stimulation. Pulmonary lymphocytes of the mice
mmunized previously by TRT exhibited significant virus-
pecific CTL activity, while those obtained from animals
mmunized by other routes showed only marginal levels
f specific lysis (Fig. 4a). When the effector cells were
reated with monoclonal antibody specific for the CD8
olecule before the cytotoxic assay was performed, spe-
ific lysis was eliminated (Fig. 4b). This result indicated
hat heterosubtypic virus-specific CTL activity detected in
he lung was mediated by CD81 T cells.
ong-lived memory heterosubtypic CTL activity in
ucosa-associated lymph nodes
To determine the longevity of heterosubtypic protec-
ion, 10 months after immunization with live virus
dorn (H3N2), lymphocytes isolated from MLN and
pleens of mice immunized intravenously or through
he TRT were assayed for CTL activity after in vitro
timulation. Heterosubtypic CTL activity against
R8/34 (H1N1)-infected target cells was detected in
he spleen regardless of the route of immunization
gans following immunization by different routes: BALB/c mice were
ated. Four weeks later, on the day of challenge, five mice from each
ns were in vitro stimulated and assayed for CTL activity against H1N1
racting nonspecific cytotoxic activity against mock-infected P815 targethoid or
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54 NGUYEN ET AL.Fig. 5). However, heterosubtypic CTL activity was de-
ected in MLN of mice immunized through the TRT but
ot in mice immunized intravenously. This activity in
he MLN was approximately 70% of that detected in
LN of the mice 1 month after immunization. Again, an
ssociation between the long-lived memory hetero-
ubtypic CTL induced at MLN and host recovery after
hallenge was maintained after 10 months (Fig. 6a).
he percentage of animals surviving was slightly less
han that of mice challenged 1 month after immuniza-
FIG. 4. CD81 cell-mediated specific CTL activity in the lung: Two d
pecific CTL activity of lymphocytes freshly isolated from the lung and
y pretreatment of effector cells with monoclonal antibody specific for
FIG. 5. Long-lived specific memory CTL responses in spleen (a) and
y different routes, as indicated; 10 months later, lymphocytes from M
gainst PR8/34 (H1N1)-infected target cells.ion; 80% of TRT immunized mice survived challenge
ith a lethal dose of mouse-adapted strain, while no
nimal immunized intravenously survived this chal-
enge. In addition, death occurred as early as day 7
fter challenge, similar to the mortality of unimmu-
ized mice (day 6). Signs of sickness were observed
s early as 2 days after challenge, as measured by
eight loss in these mice (Fig. 6b). All of the mice lost
ubstantial body weight by day 14. Survivors started to
ecover after day 14, as evidenced by gain in body
r challenging with mouse-adapted H1N1 influenza virus via the TRT,
in vitro stimulation was assayed (a). Inhibition of specific CTL activity
).
b): BALB/c mice were infected with nonpathogenic H3N2 strain Udorn
d spleen were stimulated and assayed for specific cytotoxic activityays afte
without
CD8 (bMLN (
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55CTL INDUCED IN MUCOSA-ASSOCIATED TISSUES AND PROTECTIONeight. The length of time needed to recover from
hallenge was longer in these mice challenged 1
onth after immunization.
erum antibody
Four weeks after immunization with influenza virus
train Udorn (H3N2), serum influenza-specific antibody
iters were determined before challenge with mouse-
dapted PR/8/34 (H1N1). The results are shown in Fig. 7.
o statistically significant difference in serum influenza-
pecific antibody titers was found between groups of
mmunized mice. Therefore, no correlation between
LISA antibody titers and heterosubtypic immunity was
bserved.
FIG. 6. Long-lasting heterosubtypic immunity protects from challenge
nfluenza virus type A Udorn (H3N2) by different routes, as indicated.
R/8/34 (H1N1) via the TRT. Mortality was monitored daily for at least 3
ll animals regained their initial weight (b). Values are means for 10 m
FIG. 7. Influenza-specific serum antibody titers. BALB/c mice were
mmunized with influenza virus type A Udorn (H3N2) by different routes,
s indicated. Four weeks later, ELISA antibody titers were determined
efore challenge with the heterologous mouse-adapted PR/8/34 strain
H1N1) via the TRT. The values represent the mean and SD of the
nd-point ELISA antibody titer for five mice in each group.DISCUSSION
We investigated the association between antigen-spe-
ific CTL responses induced in different lymphoid com-
artments and host protection in order to elucidate the
ffector mechanism of heterosubtypic immunity of influ-
nza virus infection. Several important conclusions can
e drawn from this study: (a) Heterosubtypic CTL re-
ponses induced in systemic lymphoid organs (spleen)
ailed to confer complete protection from lethal mucosal
nfection via TRT. (b) Antigen-specific CTL responses
nduced in mucosa-associated lymphoid tissues, drain-
ng the site of lethal infection, but not systemic lymphoid
rgans correlated with complete host protection after
ucosal challenge. (c) Induction of antigen-specific CTL
esponses in mucosa-associated lymphoid tissues after
ucosal immunization is highly region-restricted and
oes not follow the concept of a common mucosal im-
une system, as demonstrated for antibody responses.
d) Mucosal immunization induces long-lived antigen-
pecific CTL in systemic and mucosa-associated lym-
hoid tissues. In contrast, systemic immunization in-
uces preferably long-lived antigen-specific CTL in sys-
emic, but not mucosa-associated, lymphoid tissues.
BALB/c mice infected iv, ip, or i.n. with the nonpatho-
enic H3N2 strain Udorn developed high levels of het-
rosubtypic CTL activity as well as homotypic CTL re-
ponses mediated by CD81 influenza virus-specfic CTL
n the spleen. However, the survival rate after challenge
ith mouse-adapted H1N1 strain PR/8/34 was low in all
roups (20% survival). This result indicates that hetero-
ubtypic CD81 influenza virus-specific CTL responses
nduced in a systemic immune compartment, such as the
pleen, are not sufficient to protect the animals from
eath after mucosal lethal infection via TRT. Several
tudies demonstrated that heterosubtypic protection
gainst distinct influenza serotypes in mice can be pro-
ouse-adapted heterologous virus: BALB/c mice were immunized with
onths later they were challenged with heterologous mouse-adapted
(a). Body weight of individual animals was measured every 2 days until
each group.with m
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56 NGUYEN ET AL.ided by passive transfer of polyclonal or monoclonal
TL specific for the shared NP antigen (Taylor and As-
onas, 1986). However, the numbers of influenza-specific
TL used in these adoptive transfer studies were un-
hysiologically high and ranged from 3 3 106 cloned L4
c cells (Lin and Askonas, 1981), to 107 cloned CTL cells
Lukacher et al., 1984), and 108 splenocytes from immu-
ized mice (Yap et al., 1978). Furthermore, induction of
eterosubtypic CTL responses in spleen after active sys-
emic immunization with shared protein antigens, such
s the NP and M proteins, usually failed to induce com-
lete protection from challenge (Askonas et al., 1982). In
ccordance with the latter, the results obtained in our
tudy model indicate that antigen-specific CTL re-
ponses induced in systemic lymphoid organs by active
mmunization are not reflective of host protection after
ucosal challenge with heterologous virus.
TRT exposure to live virus has been a route for induc-
ion of heterosubtypic immunity to influenza since the
arly studies (Schulman and Kilbourne, 1965; Yetter et al.,
980; Liang et al., 1994; Epstein et al., 1997). We found
hat heterosubtypic immunity could be protective only
hen mice were initially exposed to influenza virus
hrough TRT, the route used for lethal challenge to test
nduction of protection. Mortality was chosen in our study
o better demonstrate heterosubtypic immunity, since
eduction of virus replication in the lung varies from one
tudy (Liang et al., 1994) to another (Epstein et al., 1997)
nd heterosubtypically immune mice exhibit only modest
eductions in lung virus titer, but significant heterosub-
ypic protection against mortality upon challenge com-
ared with controls (Epstein et al., 1997). It is therefore
ikely that variations in virus titers measured in the lungs
f mice in different experimental groups would not be
ignificant and would not reflect heterosubtypic immunity
s demonstrated by protection against mortality. In ad-
ition, the lethal dose of influenza virus (250 PFU or 53
D50) was used to achieve 100% mortality in naive mice.
his was the optimal dose in order to compare protection
mong the various groups. Mice immunized by TRT suf-
ered weight loss following immunization and it is likely
hat this route of immunization resulted in virus replica-
ion at the mucosal surface and therefore increased the
ntigenic load in mucosa-associated lymphoid tissues.
his result may be responsible for induction of a mu-
osa-related antigen-specific CTL response that is asso-
iated with protective heterosubtypic immunity to lethal
nfluenza virus infection. Other initial infection routes,
uch as iv, ip, or i.n., failed to generate total recovery
rom heterosubtypic lethal influenza challenge, although
ll immunization routes developed a high level of virus-
pecific CTL activity in the spleen as well as influenza-
pecific antibody titers in serum. Our study indicates that
D81 virus-specific CTL response induced in local mu-
osa-associated lymphoid organs is of paramount impor-
ance for successful protection. Indeed, we found a cor-elation between protective heterosubtypic immunity and
eterosubtypic CD81 influenza virus-specific CTL re-
ponses induced in the MLN, the draining lymph nodes
f the lower respiratory tract. In addition, CD81 CTL were
ecovered from the lungs of mice infected previously
hrough TRT 2 days after challenge, but not from mice
mmunized by other routes. Although the latter group of
ice developed significant secondary heterosubtypic
TL activity in the spleen, this CTL activity did not cor-
elate with protection. An early study reported induction
f heterosubtypic CTL responses in MLN of mice after
nitial ip immunization followed by TRT challenge with a
eterologous serotype (Bennink et al., 1978). In this
tudy, CTL activity was detected in MLN on day 4, but not
ay 2, after challenge. TRT challenge could have en-
anced the induction of CTL on day 4 in the MLN follow-
ng the primary ip immunization, since primary CLT ac-
ivity in MLN normally is detected on days 4, 5, and 6
fter TRT challenge of naive mice (data not shown). In
ur study, the CTL responses following in vitro restimu-
ation were assayed before the challenge, i.e., 30 days
fter the initial immunization with heterologous virus, in
rder to confirm induction of heterosubtypic CTL re-
ponses by primary immunization through different
outes. It is interesting that immunization by TRT, but not
ther immunization routes, induced memory antigen-
pecific CTL responses in MLN that differentiated into
TL effectors, early after the challenge, i.e., on day 2, in
he lungs. This CTL activity seems to play an important
ole in host recovery, since naive mice do not survive
hallenge, although they do develop CTL in MLN, but at
east 2 days later. The involvement of T cells in hetero-
ubtypic immunity to lethal influenza A virus infection is
till under investigation. Previous T cell depletion studies
ontradicted each other, in that antigen-specific CTL in
he lungs seem to control virus replication in one report
Liang et al., 1994), while in other investigations depletion
f T cells had no significant effect on heterosubtypic
mmune protection and virus clearance in the lungs
Bender et al., 1994; Epstein et al., 1997). In our study,
D81 CTL responses induced in MLN after TRT immu-
ization correlated with host survival upon challenge.
Because mucosal immunization induced both primary
nd secondary virus-specific CTL responses in regional
ucosa-associated lymphoid tissues, it can be hypoth-
sized that shortly after challenge, virus-specific CTL
emory cells in the regional lymph nodes become ef-
ector CTL and localize to the site of infection. Indeed,
his concept is supported by recent studies with Sendai
irus (Hou and Doherty, 1993) and by the kinetics of
ytokine mRNA expression after influenza virus infection
Carding et al., 1993). Local immunity should be a more
ffective way to combat pathogens in the respiratory
ract, since as many as 107 cloned CTL cells were
eeded for adoptive transfer to generate systemic het-
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57CTL INDUCED IN MUCOSA-ASSOCIATED TISSUES AND PROTECTIONrosubtypic immunity able to clear influenza infection in
he lungs (Lukacher et al., 1984).
With regard to the compartmentalization of the virus-
pecific CTL responses, our data suggest that the distri-
ution of influenza-specific CTL responses in lymph
odes, associated with the mucosal surface of the respi-
atory tract, is highly dependent on the route of initial
mmunization. For example, immunization throughout the
espiratory tract was the only route to induce a signifi-
ant CTL response in MLN. On the other hand, CTL
esponses induced in spleen and cervical lymph nodes
CLN) were independent of immunization route. Further-
ore, CTL effectors induced in CLN do not correlate with
ost survival and reflected CTL activity in the spleen,
uggesting a strong link of CLN with the systemic com-
artment rather than the lower respiratory tract. CTL
ffectors detected in CLN presumably play a role in virus
learance in the upper respiratory tract based on their
ocation. Induction of compartmentalized virus-specific
TL responses in mucosa-associated lymphoid tissues
nd their importance in immune protection have been
eported previously (Gallichan et al., 1993). Although pro-
ective immunity was induced following i.n. immuniza-
ion, this i.n. immunization protocol very likely involved
he entire respiratory tract based on the relatively large
olume of inoculum given to anesthetized mice. Our
mmunization protocol distinguishes between the i.n. im-
unization route and the TRT and demonstrates that
nduction of protective antiviral memory CTL in mucosal
issues is dependent on site-specific immunization. Thus,
ell-mediated immune responses seem to play an im-
ortant role in mucosal immune protection. Mucosal
mmunity has previously been discussed almost exclu-
ively with regard to humoral immunity (McDermott and
ienenstock, 1979; Mestecky, 1987; McGhee et al., 1992;
estecky and Jackson, 1994; Russell et al., 1999). In
ontrast to protective mucosal humoral immunity, virus-
pecific CTL responses after mucosal immunization are
estricted to the immunized region (draining lymph
odes), since initial i.n. and intravaginal immunization
id not induce CTL responses in MLN or confer protec-
ion against heterologous virus challenge (data not
hown).
Finally, the effect of initial immunization on compart-
entalized induction of memory heterosubtypic influ-
nza virus-specific CTL responses, and their role in re-
overy after lethal infection with heterosubtypic virus,
as best demonstrated by challenge experiments 10
onths after initial immunizations. Long-lasting memory
TL responses were observed in systemic lymphoid
rgans, such as spleen, regardless of the route of initial
mmunization. However, the compartmentalized memory
TL response in the MLN was observed in animals only
fter immunization throughout the TRT. A recent study of
ecombinant adenovirus vector expressing glycoprotein
of herpes simplex virus (Gallichan and Rosenthal,996) has indicated that long-lived CTL responses com-
artmentalized into mucosa-associated lymphoid tis-
ues (MLN) or systemic lymphoid organs (spleen) de-
ending on the route of immunization, i.e., to mucosal
ites following i.n. administration and to systemic sites
ollowing ip administration. Thus, no systemic antigen-
pecific CTL response was observed following i.n. im-
unization with recombinant adenovirus vector, while
mmunization with influenza virus by TRT induced anti-
en-specific CTL responses in mucosa-associated lym-
hoid tissue (MLN) as well as in the spleen, a systemic
ymphoid organ. This distinct pattern of compartmental-
zation of long-lived virus-specific CTL responses to re-
ombinant adenovirus might be due to different patho-
enic characteristics of this virus vector, although no
ata have been reported to confirm this notion. Ten
onths after initial immunization, heterosubtypic CTL
esponses declined, resulting in prolonged sickness
pon challenge prior to recovery. The CTL activity ob-
erved in the MLN was nevertheless associated with
urvival upon intrapulmonary challenge.
In conclusion, we demonstrated that CD8-mediated
eterosubtypic virus-specific CTL response induced in
ucosa-associated lymphoid tissues associated with
he site of infection correlated with heterosubtypic im-
unity to lethal influenza virus infection. However, the
uestion whether the CTL-mediated lysis of virus-in-
ected cells is the only or primary effector mechanism in
eterosubtypic immunity is still open for debate. The
nduction and maintenance of the heterosubtypic CTL
esponse in mucosa-associated lymphoid tissues are
ighly dependent on the route of immunization. These
esults shed new light on the importance of cell-medi-
ted heterosubtypic immunity at mucosal surfaces and
hould be an important consideration in the development
f new protective mucosal vaccines against variant
trains of influenza and HIV.
MATERIALS AND METHODS
ice
BALB/c (H-2d) mice were purchased at 6 weeks of age
rom Charles River Laboratories (Raleigh, NC). All mice
ere maintained in horizontal lamina flow cabinets and
ere provided sterile food and water ad libitum. The
ice used in the experiments were between 8 and 10
eeks of age.
iruses
Influenza virus strain A/Udorn/307/72 (H3N2) (a gift
rom Dr. B. Murphy, National Institutes of Health, Be-
hesda, MD) was grown in the allantoic cavity of 10-day-
ld embryonated hen eggs for 48 h at 35–36°C. The fluid
as clarified by centrifugation at 4000 g for 20 min at
°C. Virus was pelleted at 100,000 g for 45 min and
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58 NGUYEN ET AL.entrifuged on a sucrose gradient (15–55%) at 100,000 g
or 2 h. Purified virus was aliquoted and stored frozen at
70°C. Influenza virus PR/8/34 (H1N1) (a gift from Dr.
. M. Moran, Mount Sinai School of Medicine, New York,
Y) was grown in the MDCK cell line (ATCC, Rockville,
D), and the virus was purified from culture superna-
ants by sucrose gradient centrifugation, as described
bove. A mouse-adapted virus grown and isolated from
he homogenized lungs of intranasally infected mice was
sed for infection.
LISA
Influenza-specific antibodies were measured by
LISA. The assay was performed in 96-well polystyrene
icrotiter plates (Dynatech, Alexandria, VA) coated with
urified influenza virus type A/Udorn, at a concentration
f 0.5 mg/ml. Dilutions of serum were incubated over-
ight on coated and blocked ELISA plates, and the
ound immunoglobulins were detected with horseradish
eroxidase-labeled F(ab9)2 of goat IgG against mouse Ig
Southern Biotechnology Associates, Birmingham, AL).
t the end of the incubation time (3 h at 37°C), the
eroxidase substrate 2,29-azino-bis-(3-ethylbenzthiazo-
ine) sulfonic acid (Sigma, St. Louis, MO) in citrate buffer
pH 4.2) containing 0.0075% H2O2 was added. The color
eveloped was measured in a Vmax photometer (Molec-
lar Devices, Palo Alto, CA) at 414 nm. The reproducibility
f the assay was ascertained by applying on each plate
control hyperimmune mouse serum. The results were
xpressed as end-point titration values.
mmunizations and challenges of mice
Mice were infected intranasally while awake by de-
ositing 10 ml of virus suspension into the nostrils (5
l/each nostril). Ketamine-anesthetized mice received 50
l of virus inoculum for intrapulmonary immunization or
RT infection. For intravenous and intraperitoneal immu-
izations, 200 ml of virus suspension was injected into
he tail vein or the peritoneal cavity of each mouse,
espectively. All virus suspensions were adjusted to con-
ain the same amount of virus (107 PFU). Before virus
hallenge, as a proof of successful initial infection, all
ice were tested for the presence of virus-specific se-
um antibody by ELISA. Mice without virus-specific anti-
odies were excluded from the experiments. For virus
hallenges, ketamine-anesthetized mice were infected
hroughout the TRT with 250 PFU (53 LD50) resuspended
n 50 ml PBS per animal.
ells
EL-4 (H-2b) T cell lymphoma and P815 (H-2d) mastocy-
oma cells (ATCC) were maintained in standard complete
edium (RPMI 1640; Gibco, Grand Island, NY) containing
0% fetal bovine serum (FBS) and antibiotics. Hybridoma
.155 (TIB-211, ATCC) secretes a rat monoclonal IgMntibody specific for all mouse Lyt 2 (CD8) alleles. These
ntibodies can inhibit T-cell-mediated cytolysis in the
bsence of complement (Sarmiento et al., 1982). Hybrid-
ma GK1.5 (TIB-207, ATCC) produces a rat monoclonal
ntibody (IgG2b) specific for murine L3T4 (CD4) (Sar-
iento et al., 1980).
eneration of antigen-specific CTL effector cells
Effector cells were generated from BALB/c (H-2d) mice
nfected by different routes with influenza virus type A,
train Udorn (H3N2), or intravenously with mouse-
dapted PR/8/34 (H1N1) (107 PFU/mouse). After sacrifice
f infected mice, spleens, cervical lymph nodes, lungs,
nd mediastinal lymph nodes were harvested from five
ice per group and single-cell suspensions were pooled
or further analysis. A portion of the spleen cell suspen-
ion (stimulator cells) was infected with influenza virus
ype A/Udorn at multiplicity of infection (m.o.i.) of 2–4 or
ith PR/8/34 at a m.o.i. of 4–6 in a small volume (0.2 ml)
f PBS or RPMI 1640 medium without FBS. After incuba-
ion for 30 min at 37°C/5% CO2, RPMI 1640 complete
edium was added, and the cell suspension was incu-
ated for at least 3 h, irradiated (3000 R), washed, and
ixed with the remaining splenocytes (responder cells)
t a ratio of 2:1 (3–4 3 106 responder cells/ml) in CTL
omplete medium containing 10% FBS, 10 mM HEPES,
00 U/ml of penicillin, 100 mg/ml of streptomycin, 0.03%
lutamine, and 3 3 1025 M 2-mercaptoethanol. Murine
IL-2 (R&D Systems, Inc., Minneapolis, MN) was added
o cultures at day 3 (20 U/ml), followed by an additional
-day incubation at 37°C/5% CO2, after which effector
ells were washed and tested with virus-infected MHC-
atched target cells in a 51Cr release assay.
reparation of target cells
P815 (H-2d) and EL-4 (H-2b) cells were infected at a
.o.i. of 5 with Udorn or PR/8/34 influenza viruses in 100
l of incomplete medium (without serum) for 20 min at
7°C. The cells were washed to remove unbound virus
nd were cultured for 2 h in 500 ml of complete medium
ontaining 100 mCi of 51Cr per 106 cells. Prior to assess-
ent of cytotoxic activity, 51Cr-labeled cells were washed
hree times. The cells were counted and used for target
ells in the cytotoxic assay, as described below.
ytotoxic assay
The 51Cr-labeled P815 or EL-4 target cells were
ashed three times and resuspended in complete me-
ium at 105 cells/ml; 100-ml aliquots of the cell suspen-
ion were added to 96-well, round-bottom microtiter
lates containing triplicate 100-ml samples of serially
iluted effector cells. The microtiter plates were centri-
uged at 400 g for 5 min and then incubated for 4 h at
7°C/5% CO2. The level of released radioactivity in 100 ml
f supernatant from each well was measured in a
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59CTL INDUCED IN MUCOSA-ASSOCIATED TISSUES AND PROTECTIONamma counter (Cobra II Auto-Gamma, Packard Instru-
ent Co., Downers Grove, IL). Specific lysis was calcu-
ated from the 51Cr released in counts per minute (cpm)
sing the formula % specific lysis 5 (experimental
pm 2 spontaneous cpm)/(maximal release cpm 2
pontaneous cpm) 3 100; cpm for spontaneous and
aximal release was determined by incubating target
ells with either 100 ml of medium or 100 ml of 5% Triton
-100, respectively. Spontaneous release of 51Cr in the
bsence of effector cells was usually less than 15% and
id not exceed 20%. SEMs were always less than 5% of
he mean value and are not included.
tatistics
Data were analyzed with InStat 2.00. Student’s t test
two-tailed) was used for comparison of mean values
etween groups of mice.
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